ZenLens: 13-19 October 2025

Governance Updates: 13–19 October

The week of 13–19 October highlighted how shareholder activism and governance pressures continue to reshape the corporate landscape across industries.

In the healthcare sector, one well-known private hospital operator entered early talks on strategic options, including a potential sale, after years of underperformance and renewed calls from an activist fund. In the consumer space, a major European sportswear group faced suggestions of a potential “family reunion” with its historic rival if management cannot deliver a turnaround — a reminder of how deeply investors are questioning strategy.

Industrial giants were not immune either, as investors pressed one conglomerate to cut back its majority holding in a listed subsidiary to simplify its structure and free up capital for growth. At the same time, a global food manufacturer saw its long-time chairman step aside following investor criticism after the company lost two chief executives in just over a year.

In London, a technology firm providing monitoring solutions experienced direct shareholder action, with investors forcing a change at the top of its board. Meanwhile, Europe’s largest carmaker confirmed its CEO will remain in place until 2030, while ending a dual leadership role that had drawn governance concerns.

The media and advertising space also came into play, with an Abu Dhabi-based investor exploring a potential takeover of a debt-laden outdoor advertising group that has been under activist pressure to consider a sale.

Finally, the proxy advisory industry itself saw a pivotal shift: one of the leading firms announced plans to phase out its house voting guidelines from 2027, replacing them with more tailored, investor-focused frameworks.

The common thread is clear: activists and investors are pushing harder, governance models are being tested, and boards must adapt faster in a volatile, stewardship-driven environment

👉 Request our newsletter for deeper insights.